speb/financial-data huggingface dataset:
BIOX balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 2402692.00
BIOX balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 32214878.00
BIOX income_statement (quarterly, 2024-12-31) — Write Off: 1738911.00
BIOX income_statement (quarterly, 2025-03-31) — +Operating Expense: 12700000.00
BIOX income_statement (quarterly, 2025-03-31) — +Total Revenue: 50100000.00
BIOX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 123602449.00
BIOX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 187509041.00
BIOX balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -13025288.00
BIOX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 326933622.00
BIOX balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -8695786.00
BIOX income_statement (quarterly, 2025-03-31) — Amortization: 1327796.00
BIOX cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 6525009.00
BIOX cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 6525009.00
BIOX income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 1327796.00
BIOX balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 444530.00
BIOX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 62800000.00
BIOX income_statement (quarterly, 2025-03-31) — Basic EPS: 0.04
BIOX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 25031216.00
BIOX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -5910274.00
BIOX cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -3465992.00
BIOX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 16536564.00
BIOX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 6500.00
BIOX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 38456989.00
BIOX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 39346382.00
BIOX cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
BIOX balance_sheet (quarterly, 2025-03-31) — Cash Financial: 38456989.00
BIOX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -10031885.00
BIOX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -5226778.00
BIOX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 23542855.00
BIOX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -15383677.00
BIOX cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: -2676513.00
BIOX cash_flow (quarterly, 2025-03-31) — Change In Inventory: 12145462.00
BIOX cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -730628.00
BIOX cash_flow (quarterly, 2025-03-31) — Change In Payable: -18060190.00
BIOX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -18060190.00
BIOX cash_flow (quarterly, 2025-03-31) — Change In Receivables: 31484441.00
BIOX cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: -2676513.00
BIOX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 24839085.00
BIOX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 32067785.00
BIOX cash_flow (quarterly, 2025-03-31) — Changes In Cash: 8153184.00
BIOX balance_sheet (quarterly, 2025-03-31) — Common Stock: 6500.00
BIOX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 308712543.00
BIOX cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
BIOX balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 16832778.00
BIOX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 32000000.00
BIOX balance_sheet (quarterly, 2025-03-31) — Current Assets: 338207944.00
BIOX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 5639789.00
BIOX balance_sheet (quarterly, 2025-03-31) — Current Debt: 181074252.00
BIOX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 186714041.00
BIOX balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 3862028.00
BIOX balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 3862028.00
BIOX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 332309458.00
BIOX cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -5216029.00
BIOX cash_flow (quarterly, 2025-03-31) — Deferred Tax: -5216029.00
BIOX cash_flow (quarterly, 2025-03-31) — Depreciation: 4212413.00
BIOX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 10737422.00
BIOX income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 2584985.00
BIOX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 10737422.00
BIOX income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 2584985.00
BIOX income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 1257189.00
BIOX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 62800000.00
BIOX income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.04
BIOX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 2600000.00
BIOX balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 872840.00
BIOX balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Non Current: 18032217.00
BIOX balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 269498.00
BIOX balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Non Current: 800596.00
BIOX income_statement (quarterly, 2025-03-31) — EBIT: 4100000.00
BIOX income_statement (quarterly, 2025-03-31) — EBITDA: 14837422.00
BIOX income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -900000.00
BIOX cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 943603.00
BIOX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 1126699.00
BIOX cash_flow (quarterly, 2025-03-31) — End Cash Position: 38456989.00
BIOX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -12683136.00
BIOX balance_sheet (quarterly, 2025-03-31) — Finished Goods: 68380848.00
BIOX balance_sheet (quarterly, 2025-03-31) — Fixed Assets Revaluation Reserve: -160702.00
BIOX balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: 181616.00
BIOX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 17427735.00
BIOX cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -7547697.00
BIOX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 7694896.00
BIOX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -400000.00
BIOX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 20914.00
BIOX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 16874149.00
BIOX balance_sheet (quarterly, 2025-03-31) — Goodwill: 112163432.00
BIOX balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 293986835.00
BIOX balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 196204827.00
BIOX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 105038027.00
BIOX income_statement (quarterly, 2025-03-31) — Gross Profit: 18100000.00
BIOX balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 3505260.00
BIOX income_statement (quarterly, 2025-03-31) — Insurance And Claims: 729922.00
BIOX income_statement (quarterly, 2025-03-31) — Interest Expense: 5300000.00
BIOX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 5300000.00
BIOX cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -4110979.00
BIOX cash_flow (quarterly, 2025-03-31) — Interest Received Cfo: 1012954.00
BIOX balance_sheet (quarterly, 2025-03-31) — Inventories Adjustments Allowances: -2761329.00
BIOX balance_sheet (quarterly, 2025-03-31) — Inventory: 93427051.00
BIOX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 565479956.00
BIOX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -2501689.00
BIOX balance_sheet (quarterly, 2025-03-31) — Investment Properties: 525767.00
BIOX balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 444530.00
BIOX balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 39565258.00
BIOX cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 61586320.00
BIOX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 10896775.00
BIOX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 75693161.00
BIOX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 86589936.00
BIOX cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 61586320.00
BIOX cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -67556922.00
BIOX balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 39120728.00
BIOX balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 1135438.00
BIOX balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 19617973.00
BIOX balance_sheet (quarterly, 2025-03-31) — Minority Interest: 36264029.00
BIOX income_statement (quarterly, 2025-03-31) — Minority Interests: 300000.00
BIOX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
BIOX balance_sheet (quarterly, 2025-03-31) — Net Debt: 218310424.00
BIOX income_statement (quarterly, 2025-03-31) — Net Income: 2600000.00
BIOX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 2600000.00
BIOX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 2400000.00
BIOX income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -3900000.00
BIOX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2600000.00
BIOX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 6500000.00
BIOX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -10073094.00
BIOX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 2300000.00
BIOX cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -28602.00
BIOX income_statement (quarterly, 2025-03-31) — Net Interest Income: -5200000.00
BIOX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 668165.00
BIOX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -5970602.00
BIOX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -5970602.00
BIOX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -5200000.00
BIOX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 49696.00
BIOX balance_sheet (quarterly, 2025-03-31) — Net PPE: 92012739.00
BIOX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -2400349.00
BIOX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 14725708.00
BIOX balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 19714721.00
BIOX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 13970973.00
BIOX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 31924025.00
BIOX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 1436912.00
BIOX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 13970973.00
BIOX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 30487113.00
BIOX balance_sheet (quarterly, 2025-03-31) — Non Current Note Receivables: 230000.00
BIOX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 15237422.00
BIOX income_statement (quarterly, 2025-03-31) — Normalized Income: 6760000.00
BIOX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 23338009.00
BIOX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -6604094.00
BIOX income_statement (quarterly, 2025-03-31) — Operating Income: 5400000.00
BIOX income_statement (quarterly, 2025-03-31) — Operating Revenue: 50100000.00
BIOX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 60309910.00
BIOX cash_flow (quarterly, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 4145890.00
BIOX balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 181074252.00
BIOX balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1795985.00
BIOX balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 31123364.00
BIOX income_statement (quarterly, 2025-03-31) — Other Gand A: 4870325.00
BIOX income_statement (quarterly, 2025-03-31) — Other Income Expense: -1300000.00
BIOX balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 181823403.00
BIOX balance_sheet (quarterly, 2025-03-31) — Other Inventories: 1407402.00
BIOX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 7106076.00
BIOX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 478212.00
BIOX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 365007.00
BIOX income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 12700000.00
BIOX balance_sheet (quarterly, 2025-03-31) — Other Payable: 1087799.00
BIOX balance_sheet (quarterly, 2025-03-31) — Other Properties: 29693758.00
BIOX balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1568730.00
BIOX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 889393.00
BIOX income_statement (quarterly, 2025-03-31) — Other Special Charges: -139899.00
BIOX income_statement (quarterly, 2025-03-31) — Other Taxes: 1726377.00
BIOX balance_sheet (quarterly, 2025-03-31) — Payables: 132105502.00
BIOX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 132105502.00
BIOX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 7831902.00
BIOX balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 6497954.00
BIOX income_statement (quarterly, 2025-03-31) — Pretax Income: -1200000.00
BIOX balance_sheet (quarterly, 2025-03-31) — Properties: 38893518.00
BIOX cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 594774.00
BIOX cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -28602.00
BIOX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -4443927.00
BIOX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -2415680.00
BIOX balance_sheet (quarterly, 2025-03-31) — Raw Materials: 26400130.00
BIOX balance_sheet (quarterly, 2025-03-31) — Receivables: 198936557.00
BIOX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 32000000.00
BIOX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 10737422.00
BIOX cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -67556922.00
BIOX cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
BIOX income_statement (quarterly, 2025-03-31) — Research And Development: 3659747.00
BIOX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -17156979.00
BIOX income_statement (quarterly, 2025-03-31) — Salaries And Wages: 11273902.00
BIOX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 5112092.00
BIOX cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 15331.00
BIOX income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 4139328.00
BIOX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 21013477.00
BIOX balance_sheet (quarterly, 2025-03-31) — Share Issued: 62712602.00
BIOX income_statement (quarterly, 2025-03-31) — Special Income Charges: 7965685.00
BIOX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1145761.00
BIOX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 308712543.00
BIOX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 14725708.00
BIOX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -140000.00
BIOX income_statement (quarterly, 2025-03-31) — Tax Provision: -3600000.00
BIOX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.35
BIOX balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 8985946.00
BIOX balance_sheet (quarterly, 2025-03-31) — Total Assets: 798214237.00
BIOX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 384405704.00
BIOX balance_sheet (quarterly, 2025-03-31) — Total Debt: 273303977.00
BIOX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 344976572.00
BIOX income_statement (quarterly, 2025-03-31) — Total Expenses: 44700000.00
BIOX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 453237665.00
BIOX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 460006293.00
BIOX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 120928207.00
BIOX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 4300000.00
BIOX income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -100000.00
BIOX balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 7145756.00
BIOX income_statement (quarterly, 2025-03-31) — Total Unusual Items: -400000.00
BIOX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -400000.00
BIOX balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 0.00
BIOX balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 2402692.00
BIOX balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 32214878.00
BIOX balance_sheet (quarterly, 2025-03-31) — Working Capital: 5898486.00
BIOX income_statement (quarterly, 2025-03-31) — Write Off: -130890.00
BIOX income_statement (annual, 2025-06-30) — +Operating Expense: 128914798.00
BIOX income_statement (quarterly, 2025-06-30) — +Operating Expense: 30263316.00
BIOX income_statement (annual, 2025-06-30) — +Total Revenue: 333343987.00
BIOX income_statement (quarterly, 2025-06-30) — +Total Revenue: 74367748.00
BIOX balance_sheet (annual, 2025-06-30) — Accounts Payable: 91577431.00
BIOX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 91577431.00
BIOX balance_sheet (annual, 2025-06-30) — Accounts Receivable: 165859933.00
BIOX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 165859933.00
BIOX balance_sheet (annual, 2025-06-30) — Accumulated Depreciation: -13765134.00
BIOX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -13765134.00
BIOX balance_sheet (annual, 2025-06-30) — Additional Paid In Capital: 329219667.00
BIOX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 329219667.00
BIOX balance_sheet (annual, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -14559408.00
BIOX balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -14559408.00
BIOX income_statement (annual, 2025-06-30) — Amortization: 5723529.00
BIOX income_statement (quarterly, 2025-06-30) — Amortization: 1356495.00
BIOX cash_flow (annual, 2025-06-30) — Amortization Cash Flow: 11154731.00
BIOX cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 2265217.00
BIOX cash_flow (annual, 2025-06-30) — Amortization Of Intangibles: 11154731.00
BIOX cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 2265217.00
BIOX income_statement (annual, 2025-06-30) — Amortization Of Intangibles Income Statement: 5723529.00
BIOX income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 1356495.00
BIOX balance_sheet (annual, 2025-06-30) — Available For Sale Securities: 58.00
BIOX balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 58.00
BIOX income_statement (annual, 2025-06-30) — Basic Average Shares: 63200000.00
BIOX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 63200000.00
BIOX income_statement (annual, 2025-06-30) — Basic EPS: -0.83
BIOX income_statement (quarterly, 2025-06-30) — Basic EPS: -0.70
BIOX cash_flow (annual, 2025-06-30) — Beginning Cash Position: 44473270.00
BIOX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 38456989.00
BIOX cash_flow (annual, 2025-06-30) — Capital Expenditure: -14607453.00
BIOX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2180918.00
BIOX cash_flow (annual, 2025-06-30) — Capital Expenditure Reported: -8614448.00
BIOX cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -1712379.00
BIOX balance_sheet (annual, 2025-06-30) — Capital Lease Obligations: 16411981.00
BIOX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 16411981.00
BIOX balance_sheet (annual, 2025-06-30) — Capital Stock: 6500.00
BIOX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 6500.00
BIOX balance_sheet (annual, 2025-06-30) — Cash And Cash Equivalents: 32695079.00
BIOX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 32695079.00
BIOX balance_sheet (annual, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 34735117.00
BIOX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 34735117.00
BIOX cash_flow (annual, 2025-06-30) — Cash Dividends Paid: 0.00
BIOX cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
BIOX balance_sheet (annual, 2025-06-30) — Cash Equivalents: 13206934.00
BIOX balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 13206934.00
BIOX balance_sheet (annual, 2025-06-30) — Cash Financial: 19488145.00
BIOX balance_sheet (quarterly, 2025-06-30) — Cash Financial: 19488145.00
BIOX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Financing Activities: -50706103.00
BIOX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -25710458.00
BIOX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Investing Activities: -6128891.00
BIOX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 1486303.00
BIOX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Operating Activities: 49905611.00
BIOX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 26767965.00
BIOX cash_flow (annual, 2025-06-30) — Change In Inventory: 34910189.00
BIOX cash_flow (quarterly, 2025-06-30) — Change In Inventory: 2070203.00
BIOX cash_flow (annual, 2025-06-30) — Change In Other Working Capital: -8152819.00
BIOX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -7338967.00
BIOX cash_flow (annual, 2025-06-30) — Change In Payable: -32039367.00
BIOX cash_flow (quarterly, 2025-06-30) — Change In Payable: 17554690.00
BIOX cash_flow (annual, 2025-06-30) — Change In Payables And Accrued Expense: -32039367.00
BIOX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 17554690.00
BIOX cash_flow (annual, 2025-06-30) — Change In Receivables: 24582855.00
BIOX cash_flow (quarterly, 2025-06-30) — Change In Receivables: 16791719.00
BIOX cash_flow (annual, 2025-06-30) — Change In Working Capital: 19300858.00
BIOX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 29077645.00
BIOX cash_flow (annual, 2025-06-30) — Changes In Account Receivables: 25499217.00
BIOX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 17990810.00
BIOX cash_flow (annual, 2025-06-30) — Changes In Cash: -6929383.00
BIOX cash_flow (quarterly, 2025-06-30) — Changes In Cash: 2543810.00
BIOX balance_sheet (annual, 2025-06-30) — Common Stock: 6500.00
BIOX balance_sheet (quarterly, 2025-06-30) — Common Stock: 6500.00
BIOX balance_sheet (annual, 2025-06-30) — Common Stock Equity: 262808684.00
BIOX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 262808684.00
BIOX cash_flow (annual, 2025-06-30) — Common Stock Payments: -926899.00
BIOX cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
BIOX balance_sheet (annual, 2025-06-30) — Construction In Progress: 16858762.00
BIOX balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 16858762.00
BIOX income_statement (annual, 2025-06-30) — Cost Of Revenue: 205191093.00
BIOX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 51020643.00
BIOX balance_sheet (annual, 2025-06-30) — Current Assets: 308311497.00
BIOX balance_sheet (quarterly, 2025-06-30) — Current Assets: 308311497.00
BIOX balance_sheet (annual, 2025-06-30) — Current Capital Lease Obligation: 6884042.00
BIOX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 6884042.00
BIOX balance_sheet (annual, 2025-06-30) — Current Debt: 221998571.00
BIOX balance_sheet (quarterly, 2025-06-30) — Current Debt: 221998571.00
BIOX balance_sheet (annual, 2025-06-30) — Current Debt And Capital Lease Obligation: 228882613.00
BIOX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 228882613.00
BIOX balance_sheet (annual, 2025-06-30) — Current Deferred Liabilities: 4282668.00
BIOX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 4282668.00
BIOX balance_sheet (annual, 2025-06-30) — Current Deferred Revenue: 4282668.00
BIOX balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 4282668.00
BIOX balance_sheet (annual, 2025-06-30) — Current Liabilities: 337985971.00
BIOX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 337985971.00
BIOX cash_flow (annual, 2025-06-30) — Deferred Income Tax: 1273616.00
BIOX cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 6745171.00
BIOX cash_flow (annual, 2025-06-30) — Deferred Tax: 1273616.00
BIOX cash_flow (quarterly, 2025-06-30) — Deferred Tax: 6745171.00
BIOX cash_flow (annual, 2025-06-30) — Depreciation: 11027512.00
BIOX cash_flow (quarterly, 2025-06-30) — Depreciation: 2643451.00
BIOX cash_flow (annual, 2025-06-30) — Depreciation Amortization Depletion: 22182243.00
BIOX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 4908668.00
BIOX income_statement (annual, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 10589659.00
BIOX income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 2295337.00
BIOX cash_flow (annual, 2025-06-30) — Depreciation And Amortization: 22182243.00
BIOX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 4908668.00
BIOX income_statement (annual, 2025-06-30) — Depreciation And Amortization In Income Statement: 10589659.00
BIOX income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 2295337.00
BIOX income_statement (annual, 2025-06-30) — Depreciation Income Statement: 4866130.00
BIOX income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 938842.00
BIOX income_statement (annual, 2025-06-30) — Diluted Average Shares: 63200000.00
BIOX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 63200000.00
BIOX income_statement (annual, 2025-06-30) — Diluted EPS: -0.83
BIOX income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.70
BIOX income_statement (annual, 2025-06-30) — Diluted NI Availto Com Stockholders: -55416054.00
BIOX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -47886404.00
BIOX balance_sheet (annual, 2025-06-30) — Duefrom Related Parties Current: 277045.00
BIOX balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 277045.00
BIOX balance_sheet (annual, 2025-06-30) — Duefrom Related Parties Non Current: 21645840.00
BIOX balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Non Current: 21645840.00
BIOX balance_sheet (annual, 2025-06-30) — Dueto Related Parties Current: 286172.00
BIOX balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 286172.00
BIOX balance_sheet (annual, 2025-06-30) — Dueto Related Parties Non Current: 1007678.00
BIOX balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Non Current: 1007678.00
BIOX income_statement (annual, 2025-06-30) — EBIT: -31941752.00
BIOX income_statement (quarterly, 2025-06-30) — EBIT: -37786907.00
BIOX income_statement (annual, 2025-06-30) — EBITDA: -9759509.00
BIOX income_statement (quarterly, 2025-06-30) — EBITDA: -32878239.00
BIOX income_statement (annual, 2025-06-30) — Earnings From Equity Interest: -1126312.00
BIOX income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 43454.00
BIOX cash_flow (annual, 2025-06-30) — Earnings Losses From Equity Investments: 1126312.00
BIOX cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -43454.00
BIOX cash_flow (annual, 2025-06-30) — Effect Of Exchange Rate Changes: -4851365.00
BIOX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -8305952.00
BIOX cash_flow (annual, 2025-06-30) — End Cash Position: 32695079.00
BIOX cash_flow (quarterly, 2025-06-30) — End Cash Position: 32695079.00
BIOX cash_flow (annual, 2025-06-30) — Financing Cash Flow: -50706103.00
BIOX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -25710458.00
BIOX balance_sheet (annual, 2025-06-30) — Finished Goods: 66513747.00
BIOX balance_sheet (quarterly, 2025-06-30) — Finished Goods: 66513747.00
BIOX balance_sheet (annual, 2025-06-30) — Fixed Assets Revaluation Reserve: -160702.00
BIOX balance_sheet (quarterly, 2025-06-30) — Fixed Assets Revaluation Reserve: -160702.00
BIOX balance_sheet (annual, 2025-06-30) — Foreign Currency Translation Adjustments: 252512.00
BIOX balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: 252512.00
BIOX cash_flow (annual, 2025-06-30) — Free Cash Flow: 35298158.00
BIOX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 24587047.00
BIOX cash_flow (annual, 2025-06-30) — Gain Loss On Sale Of PPE: -7751311.00
BIOX cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -56415.00
BIOX income_statement (annual, 2025-06-30) — Gain On Sale Of Ppe: 7751311.00
BIOX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 56415.00
BIOX income_statement (annual, 2025-06-30) — Gain On Sale Of Security: -22036192.00
BIOX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -18673556.00
BIOX balance_sheet (annual, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 91810.00
BIOX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 91810.00
BIOX income_statement (annual, 2025-06-30) — General And Administrative Expense: 72468767.00
BIOX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 18475476.00
BIOX balance_sheet (annual, 2025-06-30) — Goodwill: 112163432.00
BIOX balance_sheet (quarterly, 2025-06-30) — Goodwill: 112163432.00
BIOX balance_sheet (annual, 2025-06-30) — Goodwill And Other Intangible Assets: 293336511.00
BIOX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 293336511.00
BIOX balance_sheet (annual, 2025-06-30) — Gross Accounts Receivable: 180419341.00
BIOX balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 180419341.00
BIOX balance_sheet (annual, 2025-06-30) — Gross PPE: 104718221.00
BIOX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 104718221.00
BIOX income_statement (annual, 2025-06-30) — Gross Profit: 128152894.00
BIOX income_statement (quarterly, 2025-06-30) — Gross Profit: 23347105.00
BIOX balance_sheet (annual, 2025-06-30) — Income Tax Payable: 452800.00
BIOX balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 452800.00
BIOX income_statement (annual, 2025-06-30) — Insurance And Claims: 2846208.00
BIOX income_statement (quarterly, 2025-06-30) — Insurance And Claims: 685315.00
BIOX income_statement (annual, 2025-06-30) — Interest Expense: 25629885.00
BIOX income_statement (quarterly, 2025-06-30) — Interest Expense: 7129299.00
BIOX income_statement (annual, 2025-06-30) — Interest Expense Non Operating: 25629885.00
BIOX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 7129299.00
BIOX cash_flow (annual, 2025-06-30) — Interest Paid Cff: -18932563.00
BIOX cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -2223549.00
BIOX cash_flow (annual, 2025-06-30) — Interest Received Cfo: 120568.00
BIOX cash_flow (quarterly, 2025-06-30) — Interest Received Cfo: -4471548.00
BIOX balance_sheet (annual, 2025-06-30) — Inventories Adjustments Allowances: -3506454.00
BIOX balance_sheet (quarterly, 2025-06-30) — Inventories Adjustments Allowances: -3506454.00
BIOX balance_sheet (annual, 2025-06-30) — Inventory: 89989649.00
BIOX balance_sheet (quarterly, 2025-06-30) — Inventory: 89989649.00
BIOX balance_sheet (annual, 2025-06-30) — Invested Capital: 523005281.00
BIOX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 523005281.00
BIOX cash_flow (annual, 2025-06-30) — Investing Cash Flow: -6128891.00
BIOX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 1486303.00
BIOX balance_sheet (annual, 2025-06-30) — Investment Properties: 570324.00
BIOX balance_sheet (quarterly, 2025-06-30) — Investment Properties: 570324.00
BIOX balance_sheet (annual, 2025-06-30) — Investmentin Financial Assets: 58.00
BIOX balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 58.00
BIOX balance_sheet (annual, 2025-06-30) — Investments And Advances: 39371322.00
BIOX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 39371322.00
BIOX cash_flow (annual, 2025-06-30) — Issuance Of Debt: 266390032.00
BIOX cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 126331838.00
BIOX balance_sheet (annual, 2025-06-30) — Long Term Capital Lease Obligation: 9527939.00
BIOX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 9527939.00
BIOX balance_sheet (annual, 2025-06-30) — Long Term Debt: 38198026.00
BIOX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 38198026.00
BIOX balance_sheet (annual, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 47725965.00
BIOX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 47725965.00
BIOX cash_flow (annual, 2025-06-30) — Long Term Debt Issuance: 266390032.00
BIOX cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 126331838.00
BIOX cash_flow (annual, 2025-06-30) — Long Term Debt Payments: -293955689.00
BIOX cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -148809516.00
BIOX balance_sheet (annual, 2025-06-30) — Long Term Equity Investment: 39371264.00
BIOX balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 39371264.00
BIOX balance_sheet (annual, 2025-06-30) — Long Term Provisions: 1267572.00
BIOX balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 1267572.00
BIOX balance_sheet (annual, 2025-06-30) — Machinery Furniture Equipment: 18640498.00
BIOX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 18640498.00
BIOX balance_sheet (annual, 2025-06-30) — Minority Interest: 32409878.00
BIOX balance_sheet (quarterly, 2025-06-30) — Minority Interest: 32409878.00
BIOX income_statement (annual, 2025-06-30) — Minority Interests: 3429199.00
BIOX income_statement (quarterly, 2025-06-30) — Minority Interests: 3774973.00
BIOX cash_flow (annual, 2025-06-30) — Net Business Purchase And Sale: 0.00
BIOX cash_flow (annual, 2025-06-30) — Net Common Stock Issuance: -926899.00
BIOX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
BIOX balance_sheet (annual, 2025-06-30) — Net Debt: 227501518.00
BIOX balance_sheet (quarterly, 2025-06-30) — Net Debt: 227501518.00
BIOX income_statement (annual, 2025-06-30) — Net Income: -55416054.00
BIOX income_statement (quarterly, 2025-06-30) — Net Income: -47886404.00
BIOX income_statement (annual, 2025-06-30) — Net Income Common Stockholders: -55416054.00
BIOX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -47886404.00
BIOX income_statement (annual, 2025-06-30) — Net Income Continuous Operations: -58845253.00
BIOX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -51661377.00
BIOX income_statement (annual, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -55416054.00
BIOX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -47886404.00
BIOX income_statement (annual, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -55416054.00
BIOX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -47886404.00
BIOX cash_flow (annual, 2025-06-30) — Net Income From Continuing Operations: -58845253.00
BIOX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -51661377.00
BIOX income_statement (annual, 2025-06-30) — Net Income Including Noncontrolling Interests: -58845253.00
BIOX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -51661377.00
BIOX cash_flow (annual, 2025-06-30) — Net Intangibles Purchase And Sale: -350843.00
BIOX cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -37869.00
BIOX income_statement (annual, 2025-06-30) — Net Interest Income: -33708839.00
BIOX income_statement (quarterly, 2025-06-30) — Net Interest Income: -13008551.00
BIOX cash_flow (annual, 2025-06-30) — Net Investment Purchase And Sale: 8088181.00
BIOX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 3447642.00
BIOX cash_flow (annual, 2025-06-30) — Net Issuance Payments Of Debt: -27565657.00
BIOX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -22477678.00
BIOX cash_flow (annual, 2025-06-30) — Net Long Term Debt Issuance: -27565657.00
BIOX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -22477678.00
BIOX income_statement (annual, 2025-06-30) — Net Non Operating Interest Income Expense: -33708839.00
BIOX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -13008551.00
BIOX cash_flow (annual, 2025-06-30) — Net Other Financing Charges: -3280984.00
BIOX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -1009231.00
BIOX balance_sheet (annual, 2025-06-30) — Net PPE: 90953087.00
BIOX balance_sheet (quarterly, 2025-06-30) — Net PPE: 90953087.00
BIOX cash_flow (annual, 2025-06-30) — Net PPE Purchase And Sale: -5251781.00
BIOX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -211091.00
BIOX balance_sheet (annual, 2025-06-30) — Net Tangible Assets: -30527827.00
BIOX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -30527827.00
BIOX balance_sheet (annual, 2025-06-30) — Non Current Accounts Receivable: 25955359.00
BIOX balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 25955359.00
BIOX balance_sheet (annual, 2025-06-30) — Non Current Deferred Assets: 4916980.00
BIOX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 4916980.00
BIOX balance_sheet (annual, 2025-06-30) — Non Current Deferred Liabilities: 31559832.00
BIOX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 31559832.00
BIOX balance_sheet (annual, 2025-06-30) — Non Current Deferred Revenue: 1436912.00
BIOX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 1436912.00
BIOX balance_sheet (annual, 2025-06-30) — Non Current Deferred Taxes Assets: 4916980.00
BIOX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 4916980.00
BIOX balance_sheet (annual, 2025-06-30) — Non Current Deferred Taxes Liabilities: 30122920.00
BIOX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 30122920.00
BIOX balance_sheet (annual, 2025-06-30) — Non Current Note Receivables: 230000.00
BIOX balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 230000.00
BIOX income_statement (annual, 2025-06-30) — Normalized EBITDA: 11239732.00
BIOX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -9209529.00
BIOX income_statement (annual, 2025-06-30) — Normalized Income: -41766547.35
BIOX income_statement (quarterly, 2025-06-30) — Normalized Income: -32501742.50
BIOX cash_flow (annual, 2025-06-30) — Operating Cash Flow: 49905611.00
BIOX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 26767965.00
BIOX cash_flow (annual, 2025-06-30) — Operating Gains Losses: -6624999.00
BIOX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -99869.00
BIOX income_statement (annual, 2025-06-30) — Operating Income: -761904.00
BIOX income_statement (quarterly, 2025-06-30) — Operating Income: -6916211.00
BIOX income_statement (annual, 2025-06-30) — Operating Revenue: 333343987.00
BIOX income_statement (quarterly, 2025-06-30) — Operating Revenue: 74367748.00
BIOX balance_sheet (annual, 2025-06-30) — Ordinary Shares Number: 63228239.00
BIOX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 63228239.00
BIOX cash_flow (annual, 2025-06-30) — Other Cash Adjustment Outside Changein Cash: 2557.00
BIOX cash_flow (quarterly, 2025-06-30) — Other Cash Adjustment Outside Changein Cash: 232.00
BIOX balance_sheet (annual, 2025-06-30) — Other Current Borrowings: 221998571.00
BIOX balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 221998571.00
BIOX balance_sheet (annual, 2025-06-30) — Other Current Liabilities: 1761274.00
BIOX balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1761274.00
BIOX balance_sheet (annual, 2025-06-30) — Other Equity Interest: 30748968.00
BIOX balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 30748968.00
BIOX income_statement (annual, 2025-06-30) — Other Gand A: 22329718.00
BIOX income_statement (quarterly, 2025-06-30) — Other Gand A: 5550542.00
BIOX income_statement (annual, 2025-06-30) — Other Income Expense: -23100894.00
BIOX income_statement (quarterly, 2025-06-30) — Other Income Expense: -24991444.00
BIOX balance_sheet (annual, 2025-06-30) — Other Intangible Assets: 181173079.00
BIOX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 181173079.00
BIOX balance_sheet (annual, 2025-06-30) — Other Inventories: 2378380.00
BIOX balance_sheet (quarterly, 2025-06-30) — Other Inventories: 2378380.00
BIOX cash_flow (annual, 2025-06-30) — Other Non Cash Items: 59104678.00
BIOX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 35400327.00
BIOX balance_sheet (annual, 2025-06-30) — Other Non Current Liabilities: 397774.00
BIOX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 397774.00
BIOX income_statement (annual, 2025-06-30) — Other Non Operating Income Expenses: -975341.00
BIOX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -1366188.00
BIOX income_statement (annual, 2025-06-30) — Other Operating Expenses: 2793293.00
BIOX income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 623554.00
BIOX balance_sheet (annual, 2025-06-30) — Other Payable: 1285145.00
BIOX balance_sheet (quarterly, 2025-06-30) — Other Payable: 1285145.00
BIOX balance_sheet (annual, 2025-06-30) — Other Properties: 30142835.00
BIOX balance_sheet (quarterly, 2025-06-30) — Other Properties: 30142835.00
BIOX balance_sheet (annual, 2025-06-30) — Other Receivables: 866473.00
BIOX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 866473.00
BIOX balance_sheet (annual, 2025-06-30) — Other Short Term Investments: 2040038.00
BIOX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 2040038.00
BIOX income_statement (annual, 2025-06-30) — Other Special Charges: -409356.00
BIOX income_statement (quarterly, 2025-06-30) — Other Special Charges: -222311.00
BIOX income_statement (annual, 2025-06-30) — Other Taxes: 12271870.00
BIOX income_statement (quarterly, 2025-06-30) — Other Taxes: 2035511.00
BIOX balance_sheet (annual, 2025-06-30) — Payables: 96885404.00
BIOX balance_sheet (quarterly, 2025-06-30) — Payables: 96885404.00
BIOX balance_sheet (annual, 2025-06-30) — Payables And Accrued Expenses: 96885404.00
BIOX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 96885404.00
BIOX balance_sheet (annual, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 6174012.00
BIOX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 6174012.00
BIOX balance_sheet (annual, 2025-06-30) — Prepaid Assets: 5834158.00
BIOX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 5834158.00
BIOX income_statement (annual, 2025-06-30) — Pretax Income: -57571637.00
BIOX income_statement (quarterly, 2025-06-30) — Pretax Income: -44916206.00
BIOX balance_sheet (annual, 2025-06-30) — Properties: 39076126.00
BIOX balance_sheet (quarterly, 2025-06-30) — Properties: 39076126.00
BIOX cash_flow (annual, 2025-06-30) — Provisionand Write Offof Assets: 9007212.00
BIOX cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 5835405.00
BIOX cash_flow (annual, 2025-06-30) — Purchase Of Intangibles: -350843.00
BIOX cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -37869.00
BIOX cash_flow (annual, 2025-06-30) — Purchase Of Investment: -11182107.00
BIOX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -1082178.00
BIOX cash_flow (annual, 2025-06-30) — Purchase Of PPE: -5642162.00
BIOX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -430670.00
BIOX balance_sheet (annual, 2025-06-30) — Raw Materials: 24603976.00
BIOX balance_sheet (quarterly, 2025-06-30) — Raw Materials: 24603976.00
BIOX balance_sheet (annual, 2025-06-30) — Receivables: 177752573.00
BIOX balance_sheet (quarterly, 2025-06-30) — Receivables: 177752573.00
BIOX income_statement (annual, 2025-06-30) — Reconciled Cost Of Revenue: 193598509.00
BIOX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 48407312.00
BIOX income_statement (annual, 2025-06-30) — Reconciled Depreciation: 22182243.00
BIOX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 4908668.00
BIOX cash_flow (annual, 2025-06-30) — Repayment Of Debt: -293955689.00
BIOX cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -148809516.00
BIOX cash_flow (annual, 2025-06-30) — Repurchase Of Capital Stock: -926899.00
BIOX cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
BIOX income_statement (annual, 2025-06-30) — Research And Development: 14914822.00
BIOX income_statement (quarterly, 2025-06-30) — Research And Development: 2650960.00
BIOX income_statement (annual, 2025-06-30) — Restructuring And Mergern Acquisition: 0.00
BIOX balance_sheet (annual, 2025-06-30) — Retained Earnings: -65043383.00
BIOX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -65043383.00
BIOX income_statement (annual, 2025-06-30) — Salaries And Wages: 47292841.00
BIOX income_statement (quarterly, 2025-06-30) — Salaries And Wages: 12239619.00
BIOX cash_flow (annual, 2025-06-30) — Sale Of Business: 0.00
BIOX cash_flow (annual, 2025-06-30) — Sale Of Investment: 19270288.00
BIOX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 4529820.00
BIOX cash_flow (annual, 2025-06-30) — Sale Of PPE: 390381.00
BIOX cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 219579.00
BIOX income_statement (annual, 2025-06-30) — Selling And Marketing Expense: 15876387.00
BIOX income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 4182478.00
BIOX income_statement (annual, 2025-06-30) — Selling General And Administration: 88345154.00
BIOX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 22657954.00
BIOX balance_sheet (annual, 2025-06-30) — Share Issued: 65630931.00
BIOX balance_sheet (quarterly, 2025-06-30) — Share Issued: 65630931.00
BIOX income_statement (annual, 2025-06-30) — Special Income Charges: 1036951.00
BIOX income_statement (quarterly, 2025-06-30) — Special Income Charges: -4995154.00
BIOX cash_flow (annual, 2025-06-30) — Stock Based Compensation: 4386688.00
BIOX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1033543.00
BIOX balance_sheet (annual, 2025-06-30) — Stockholders Equity: 262808684.00
BIOX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 262808684.00
BIOX balance_sheet (annual, 2025-06-30) — Tangible Book Value: -30527827.00
BIOX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -30527827.00
BIOX income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: -7349734.35
BIOX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -8284048.50
BIOX income_statement (annual, 2025-06-30) — Tax Provision: 1273616.00
BIOX income_statement (quarterly, 2025-06-30) — Tax Provision: 6745171.00
BIOX income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.35
BIOX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.35
BIOX balance_sheet (annual, 2025-06-30) — Taxes Receivable: 10749122.00
BIOX balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 10749122.00
BIOX cash_flow (annual, 2025-06-30) — Taxes Refund Paid: 0.00
BIOX balance_sheet (annual, 2025-06-30) — Total Assets: 763645080.00
BIOX balance_sheet (quarterly, 2025-06-30) — Total Assets: 763645080.00
BIOX balance_sheet (annual, 2025-06-30) — Total Capitalization: 301006710.00
BIOX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 301006710.00
BIOX balance_sheet (annual, 2025-06-30) — Total Debt: 276608578.00
BIOX balance_sheet (quarterly, 2025-06-30) — Total Debt: 276608578.00
BIOX balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 295218562.00